|
1
|
Wei WI and Kwong DL: Current management
strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol.
3:1–12. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang Y, Zhang Y and Ma S: Racial
differences in nasopharyngeal carcinoma in the United States.
Cancer Epidemiol. 37:793–802. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lang J, Hu C, Lu T, Pan J and Lin T:
Chinese expert consensus on diagnosis and treatment of
nasopharyngeal carcinoma: Evidence from current practice and future
perspectives. Cancer Manag Res. 11:6365–6376. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Adham M, Kurniawan AN, Muhtadi AI, Roezin
A, Hermani B, Gondhowiardjo S, Tan IB and Middeldorp JM:
Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence,
signs, and symptoms at presentation. Chin J Cancer. 31:185–196.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jain A, Chia WK and Toh HC: Immunotherapy
for nasopharyngeal cancer-a review. Chin Clin Oncol.
5(22)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang QY, He YQ, Xue WQ, Zhou T, Liao Y,
Zheng MQ, Jia YJ, Yuan LL and Jia WH: Association between serum
cotinine level and serological markers of Epstein-Barr virus in
healthy subjects in south china where nasopharyngeal carcinoma is
endemic. Front Oncol. 9(865)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang TM, Zhou T, He YQ, Xue WQ, Zhang JB,
Zheng XH, Li XZ, Zhang SD, Zeng YX and Jia WH: Fine-mapping of HLA
class I and II genes identified two independent novel variants
associated with nasopharyngeal carcinoma susceptibility. Cancer
Med. 7:6308–6316. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bei JX, Zuo XY, Liu WS, Guo YM and Zeng
YX: Genetic susceptibility to the endemic form of NPC. Chin Clin
Oncol. 5(15)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guo XC, Scott K, Liu Y, Dean M, David V,
Nelson GW, Johnson RC, Dilks HH, Lautenberger J, Kessing B, et al:
Genetic factors leading to chronic Epstein-Barr virus infection and
nasopharyngeal carcinoma in South East China: Study design, methods
and feasibility. Hum Genomics. 2:365–375. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang P, Zhang L, Liu H, Zhao L, Li Y,
Shen JX, Liu Q, Liu MZ and Xi M: Clinicopathologic characteristics
and prognosis of tongue squamous cell carcinoma in patients with
and without a history of radiation for nasopharyngeal carcinoma: A
matched case-control study. Cancer Res Treat. 49:695–705.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guo XC, O'Brien SJ, Winkler C, Scott K,
Hutcheson H, David V, Kessing B, Zheng YM, Liao J, Lui Y, et al:
Association study of chromosome 4 STRs polymorphisms with
nasopharyngeal carcinoma. Yi Chuan. 28:783–790. 2006.PubMed/NCBI(In Chinese).
|
|
12
|
Zhou HD, Li XL, Li GY, Zhou M, Liu HY,
Yang YX, Deng T, Ma J and Sheng SR: Effect of SPLUNC1 protein on
the pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell
Biochem. 309:191–197. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhou HD, Li GY, Yang YX, Li XL, Sheng SR,
Zhang WL and Zhao J: Intracellular co-localization of SPLUNC1
protein with nanobacteria in nasopharyngeal carcinoma epithelia
HNE1 cells depended on the bactericidal permeability increasing
protein domain. Mol Immunol. 43:1864–1871. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
He Y, Zhou G, Zhai Y, Dong X, Lv L, He F
and Yao K: Association of PLUNC gene polymorphisms with
susceptibility to nasopharyngeal carcinoma in a Chinese population.
J Med Genet. 42:172–176. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Métais JY and Dunbar CE: The MDS1-EVI1
gene complex as a retrovirus integration site: Impact on behavior
of hematopoietic cells and implications for gene therapy. Mol Ther.
16:439–449. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kurokawa M, Mitani K, Yamagata T,
Takahashi T, Izutsu K, Ogawa S, Moriguchi T, Nishida E, Yazaki Y
and Hirai H: The evi-1 oncoprotein inhibits c-Jun N-terminal kinase
and prevents stress-induced cell death. EMBO J. 19:2958–2968.
2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bei JX, Li Y, Jia WH, Feng BJ, Zhou G,
Chen LZ, Feng QS, Low HQ, Zhang H, He F, et al: A genome-wide
association study of nasopharyngeal carcinoma identifies three new
susceptibility loci. Nat Genet. 42:599–603. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1484.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ara S, Lee PS, Hansen MF and Saya H: Codon
72 polymorphism of the TP53 gene. Nucleic Acids Res.
18(4961)1990.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Emigh TH: A comparison of tests for
Hardy-Weinberg equilibrium. Biometrics. 36:627–642. 1980.PubMed/NCBI
|
|
21
|
Wu MY, Huang SJ, Yang F, Qin XT, Liu D,
Ding Y, Yang S and Wang XC: Detection of nasopharyngeal carcinoma
susceptibility with single nucleotide polymorphism analysis using
next-generation sequencing technology. Oncotarget. 8:52708–52723.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chin C, Hahn WC, Getz G and Meyerson M:
Making sense of cancer genomic data. Genes Dev. 25:534–555.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hildesheim A and Wang CP: Genetic
predisposition factors and nasopharyngeal carcinoma risk: A review
of epidemiological association studies, 2000-2011: Rosetta stone
for NPC: Genetics, viral infection, and other environmental
factors. Semin Cancer Biol. 22:107–116. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu H, Zhang X, Wu J, French SW and He Z:
New insights on the palate, lung, and nasal epithelium clone
(PLUNC) proteins: Based on molecular and functional analysis of its
homolog of YH1/SPLUNC1. Exp Mol Pathol. 100:363–369.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ou C, Sun Z, Zhang H, Xiong W, Ma J, Zhou
M, Lu J, Zeng Z, Bo X, Chen P, et al: SPLUNC1 reduces the
inflammatory response of nasopharyngeal carcinoma cells infected
with the EB virus by inhibiting the TLR9/NF-κB pathway. Oncol Rep.
33:2779–2788. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang B, Nie X, Xiao B, Xiang J, Shen S,
Gong J, Zhou M, Zhu S, Zhou J, Qian J, et al: Identification of
tissue-specific genes in nasopharyngeal epithelial tissue and
differentially expressed genes in nasopharyngeal carcinoma by
suppression subtractive hybridization and cDNA microarray. Genes
Chromosomes Cancer. 38:80–90. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang W, Zeng Z, Wei F, Chen P, Schmitt
DC, Fan S, Guo X, Liang F, Shi L, Liu Z, et al: SPLUNC1 is
associated with nasopharyngeal carcinoma prognosis and plays an
important role in all-trans-retinoic acid-induced growth inhibition
and differentiation in nasopharyngeal cancer cells. FEBS J.
281:4815–4829. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yew PY, Mushiroda T, Kiyotani K,
Govindasamy GK, Yap LF, Teo SH, Lim PV, Govindaraju S, Ratnavelu K,
Sam CK, et al: Identification of a functional variant in SPLUNC1
associated with nasopharyngeal carcinoma susceptibility among
Malaysian Chinese. Mol Carcinog. 51 (Suppl 1):E74–E82.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Heller G, Rommer A, Steinleitner K, Etzler
J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B,
Topakian T, et al: EVI1 promotes tumor growth via transcriptional
repression of MS4A3. J Hematol Oncol. 8(28)2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wilson M, Tsakraklides V, Tran M, Xiao YY,
Zhang Y and Perkins AS: EVI1 interferes with myeloid maturation via
transcriptional repression of Cebpa, via binding to two far
downstream regulatory elements. J Biol Chem. 291:13591–13607.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Steinleitner K, Rampetsreiter P, Köffel R,
Ramanathan G, Mannhalter C, Strobl H and Wieser R: EVI1 and
MDS1/EVI1 expression during primary human hematopoietic progenitor
cell differentiation into various myeloid lineages. Anticancer Res.
32:4883–4889. 2012.PubMed/NCBI
|
|
32
|
Wieser R: The oncogene and developmental
regulator EVI1: Expression, biochemical properties, and biological
functions. Gene. 396:346–357. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yuan X, Wang X, Bi K and Jiang G: The role
of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
Int J Oncol. 47:2028–2036. 2015.PubMed/NCBI View Article : Google Scholar
|
